Key Takeaways

• Rapid eMAR Market Growth: The global eMAR software market is projected to grow from $1.42 billion in 2024 to $3.83 billion by 2033, driven by healthcare digitization, cloud adoption, and increasing demand for electronic medication management systems.
• Improved Medication Safety and Clinical Efficiency: Barcode-assisted eMAR systems can reduce non-timing medication administration errors by 41.4% and potential adverse drug events by 51%, improving patient safety and healthcare workflows.
• AI, Cloud Technology, and Long-Term Care Adoption: Key eMAR system trends in 2026 include AI-powered medication monitoring, cloud-based platforms, EHR integration, mobile medication administration, and growing adoption across hospitals, nursing homes, and long-term care facilities.

---

Electronic Medication Administration Record (eMAR) systems improve medication safety, reduce administration errors, and streamline healthcare workflows. In 2026, the global eMAR software market continues to expand, with projections reaching $3.83 billion by 2033. Key trends include AI-powered medication monitoring, barcode verification, cloud-based platforms, and growing adoption across hospitals and long-term care facilities.

The healthcare industry is undergoing a major digital transformation, with Electronic Medication Administration Record (eMAR) systems becoming essential tools for improving patient safety, reducing medication errors, and streamlining clinical workflows. As hospitals, nursing homes, assisted living facilities, and long-term care providers increasingly adopt digital medication management solutions, the global eMAR market continues to experience significant growth.

Also, read our article on the Top 10 Electronic Medication Administration Record (eMAR) Systems.

According to industry estimates, the global eMAR software market was valued at $1.42 billion in 2024 and is projected to reach $3.83 billion by 2033, representing a compound annual growth rate (CAGR) of approximately 11.8%. This expansion reflects growing demand for automated medication administration, real-time clinical documentation, barcode medication administration (BCMA), and integrated electronic health record (EHR) systems.

One of the most important drivers of eMAR system adoption is the urgent need to address medication-related patient safety risks. The World Health Organization estimates that medication errors cost healthcare systems approximately $42 billion globally each year, highlighting the financial and clinical consequences of preventable medication incidents. Research published in the New England Journal of Medicine also found that barcode-assisted electronic medication administration systems can reduce non-timing medication administration errors by 41.4% and potential adverse drug events by 51%.

Beyond patient safety, eMAR software is transforming healthcare operational efficiency. Modern platforms enable nurses and caregivers to document medication administration electronically, verify patient identities, track missed doses, receive medication alerts, and maintain accurate audit trails. These capabilities are particularly valuable in long-term care environments, where complex medication schedules, workforce shortages, and increasing patient acuity create substantial operational challenges.

The competitive landscape is also evolving. Major healthcare technology providers such as Epic Systems, Oracle Health, MEDITECH, PointClickCare, and MatrixCare continue to shape the adoption of integrated eMAR solutions. Meanwhile, emerging cloud-based and mobile-first platforms are introducing artificial intelligence, predictive medication adherence analytics, automated pharmacy integrations, and real-time monitoring capabilities.

Looking ahead, several important eMAR system trends in 2026 are influencing healthcare technology investment decisions. These include the growing adoption of cloud-based medication management software, increased integration between eMAR and EHR platforms, expanded use of barcode scanning technology, stronger cybersecurity requirements, and the development of AI-powered clinical decision support tools.

For healthcare administrators, nursing directors, clinical informatics professionals, software vendors, and investors, understanding these developments is essential for evaluating technology investments and improving medication management strategies.

This comprehensive guide explores the Top 100 eMAR System Statistics, Data & Trends in 2026, covering global market size, industry growth forecasts, medication error rates, patient safety improvements, BCMA effectiveness, vendor market share, healthcare adoption patterns, and emerging technology innovations. Together, these statistics provide valuable insights into how electronic medication administration record systems are reshaping healthcare delivery and what organizations can expect from the future of digital medication management.

Before we venture further into this article, we would like to share who we are and what we do.

About 9cv9

9cv9 is a business tech startup based in Singapore and Asia, with a strong presence all over the world.

With over ten years of startup and business experience, and being highly involved in connecting with thousands of companies and startups, the 9cv9 team has listed some of the top and best companies/tools in this review.

If you like to get your company listed in our top B2B software reviews, check out our world-class 9cv9 Media and PR service and pricing plans here.

Top 100 eMAR System Statistics, Data & Trends in 2026

📊 Market Size & Growth (Stats 1–14)

1. $1.42B — The global eMAR software market was valued at $1.42 billion in 2024. This robust baseline reflects accelerating healthcare digitization mandates and regulatory pressure driving adoption across all care settings. (Grand View Research)
2. $3.83B — The global eMAR market is projected to reach $3.83 billion by 2033. This near-tripling over a decade signals that eMAR is shifting from a compliance tool to a core operational and clinical intelligence platform. (Grand View Research)
3. 11.8% CAGR — The eMAR software segment is growing at an 11.8% compound annual growth rate from 2024–2033. This outpaces general healthcare IT growth, driven by AI integration and mandatory digital-first policies in many jurisdictions. (Grand View Research)
4. $597M — The LTC eMAR sub-market was valued at $597 million in 2023. This figure underscores strong early-adoption momentum, particularly in skilled nursing and assisted living communities seeking to reduce administration errors. (Grand View Research)
5. $1.07B — The LTC eMAR sub-market is expected to reach $1.07 billion by 2030 at an 8.5% CAGR. Aging demographics and caregiver shortages are primary structural drivers ensuring sustained investment into this segment. (Grand View Research)
6. $5.51B — The broader global long-term care software market (which includes eMAR) was valued at $5.51 billion in 2024. eMAR is one of its fastest-growing application segments, demonstrating the central role of medication management in LTC digitization. (Data Bridge Market Research)
7. $12.52B — Global LTC software including eMAR is projected to reach $12.52 billion by 2032 at a 10.8% CAGR. This trajectory reflects sweeping reforms in nursing home regulation, staffing, and interoperability across high-income countries. (Data Bridge Market Research)
8. 52% North America — North America accounted for over 52% of global LTC software revenue in 2024. Strong regulatory frameworks including CMS mandates and HIPAA compliance requirements make North America the world’s most mature eMAR market. (Market.us)
9. $35.9B — The global EHR market — the primary infrastructure upon which eMAR is built — was valued at $35.9 billion in 2025. EHR-embedded eMAR modules benefit directly from this massive installed base. (Grand View Research)
10. 5.1% EHR CAGR — The EHR market is forecast to grow from $35.9B to $53.1B by 2033 at 5.1% CAGR. As EHR platforms scale, integrated eMAR functionality becomes a standard expectation rather than a premium add-on. (Grand View Research)
11. 83.7% cloud revenue — Cloud and web-based solutions account for 83.7% of EHR/eMAR revenue in 2025. This decisive shift to SaaS models is enabling eMAR deployments at smaller facilities previously priced out of enterprise software. (Grand View Research)
12. $167B US Healthcare IT — The U.S. healthcare IT software market was worth $167 billion in 2024, growing at a 15.46% CAGR toward $389 billion by 2030. eMAR is a critical node within this ecosystem, benefiting from broader digital infrastructure investment. (Research & Markets)
13. 9.4% cloud LTC CAGR — Cloud-based LTC software deployments are expanding at 9.4% CAGR through 2030. Operators cite real-time analytics, AI modules, and reduced IT overhead as primary motivators for migrating from on-premise to cloud eMAR. (Mordor Intelligence)
14. $379M Europe — The European eMAR software market was valued at $379 million in 2024. Driven by EU digital health directives and national EHR mandates in Germany, France, and the UK, Europe is the world’s second-largest eMAR market. (Growth Market Reports)

---

🛡️ Medication Errors & Patient Safety (Stats 15–35)

15. $42B annually — The global cost of medication errors is estimated at $42 billion per year, according to WHO. This staggering figure is the single most compelling business and clinical case for universal eMAR adoption. (WHO, 2024)
16. 44,000–98,000 U.S. deaths — Between 44,000 and 98,000 Americans die in hospitals annually due to medication errors — surpassing deaths from motor vehicle accidents. eMAR systems are the most evidence-backed intervention available to reduce this toll. (StatPearls, 2024)
17. 1-in-30 patients harmed — WHO estimates that 1 in every 30 patients globally experiences medication-related harm. This is not a rare edge case — it is a systemic failure that eMAR technology directly mitigates. (WHO Medication Without Harm)
18. 50% of preventable harm is medication-related — Half of all preventable harm in medical care is caused by medication-related incidents. eMAR’s role as a structural safety layer cannot be overstated given the breadth of this problem. (WHO, 2022)
19. 23% severe consequences — Nearly 1 in 4 preventable medication harms results in severe or potentially life-threatening consequences. This high severity rate reinforces why eMAR is treated as a patient safety imperative rather than a back-office tool. (WHO Systematic Review, 2024)
20. 7,000–9,000 annual deaths (FDA) — Between 7,000 and 9,000 Americans die annually from medication errors according to the FDA and AHRQ. Even at the lower bound, this represents a preventable public health crisis. (FDA/AHRQ)
21. 1.5 million annual ADEs — Adverse drug events cause approximately 1.5 million emergency department visits in the U.S. each year. eMAR’s real-time alerts and five-rights verification are designed to intercept exactly these events. (Healthy People 2030, HHS)
22. $3.5B ADE economic cost — ADEs result in $3.5 billion in excess U.S. medical costs annually. eMAR adoption at scale could recover a substantial portion of these costs through reduced hospitalizations and complications. (Healthy People 2030, HHS)
23. 6.5 errors per 100 admissions — Medication errors occur at a rate of approximately 6.5 per 100 acute hospital admissions. With millions of annual admissions, this translates to hundreds of thousands of incidents that eMAR can prevent. (StatPearls, 2024)
24. 8–25% administration error rate — Medication error rates during patient administration range from 8% to 25% across hospital and LTC settings. This wide variance reflects the inconsistency of manual systems and the case for standardized eMAR workflows. (Renew Bariatrics, 2024)
25. >100,000 FDA annual reports — The FDA receives over 100,000 medication error reports annually. This reporting burden itself is a signal that current systems are inadequate, and eMAR provides the audit trail infrastructure to both catch and document errors. (Renew Bariatrics, 2024)
26. 7 million+ patients affected annually — Over 7 million U.S. patients experience adverse effects from medication errors each year. At this scale, eMAR is not a niche clinical tool — it is foundational public health infrastructure. (Renew Bariatrics, 2024)
27. 530,000 outpatient injuries — Approximately 530,000 injury incidents at outpatient clinics result from medication errors annually in the U.S. Outpatient eMAR adoption still lags hospital deployment, representing a significant opportunity for harm reduction. (Renew Bariatrics, 2024)
28. 69.5% of UK care home residents exposed — A cross-sectional UK study found 69.5% of surveyed care home residents had been exposed to one or more medication errors. This alarming rate directly motivated the development of eMAR systems for residential care environments. (NCBI/PubMed)
29. 15% of health spending on harm consequences — In high-income countries, approximately 15% of total health expenditure goes to managing the consequences of patient harm. eMAR-driven prevention can meaningfully reduce this structural cost burden. (WHO Global Patient Safety Report, 2024)
30. 3 million global deaths annually — More than 3 million deaths globally every year are attributable to unsafe care, translating to over 134 million adverse events in hospitals in low- and middle-income countries alone. eMAR is central to the WHO’s global safety action plan. (WHO Global Patient Safety Report, 2024)
31. WHO 50% reduction target — The WHO’s Medication Without Harm Challenge sets a target of reducing severe avoidable medication-related harm by 50% globally over five years. eMAR and BCMA technology are among the primary evidence-based interventions named in the initiative. (WHO, 2022)
32. $37.6B–$50B productivity losses — Medication errors cost between $37.6 billion and $50 billion in added healthcare costs, disability, and lost productivity in the U.S. alone. eMAR represents a high-ROI investment against this economic drag. (StatPearls, 2024)
33. >200,000 preventable U.S. deaths — An estimated 200,000 or more patient deaths annually in the U.S. are attributable to preventable medical errors, a significant share of which are medication-related. (NCBI StatPearls, 2024)
34. $2B+ in Massachusetts alone — Medical errors in Massachusetts cost the state more than $2 billion in excess health insurance claims. This state-level example illustrates how national eMAR mandates could generate enormous systemic savings. (Betsy Lehman Center)
35. 45% of UK care homes failing in 2005 → 28% in 2010 — In England, 45% of care homes failed minimum medication management standards in 2005, declining to 28% by 2010 — a period coinciding with early eMAR adoption. Continued deployment is expected to drive this rate to near-zero. (NCBI/PubMed)

---

💊 BCMA-eMAR Clinical Impact (Stats 36–52)

36. 41.4% non-timing error reduction — Barcode-assisted eMAR reduces non-timing medication errors by 41.4%, based on landmark data published in the New England Journal of Medicine. This figure remains one of the most cited in clinical informatics. (NEJM, 2010)
37. 51% ADE prevention — Potential adverse drug events drop by 51% when eMAR is paired with barcode medication administration (BCMA). This translates to thousands of prevented hospitalizations and serious harms per facility annually. (TechTarget/AHRQ)
38. ~80% emergency department prevention — Emergency departments deploying BCMA-eMAR systems see medication error prevention rates approaching 80%. High-acuity environments with complex polypharmacy benefit most from automated verification. (TechTarget/AHRQ)
39. 56% ICU error reduction — A medical ICU study found medication errors decreased by 56% following robust BCMA deployment integrated with eMAR. In the ICU, where errors are most lethal, this figure is clinically transformative. (DeYoung, 2009 / NCBI PMC11958195)
40. Up to 94% combined reduction — Central automated dispensing combined with BCMA-eMAR systems can reduce medication administration errors by up to 94%. This near-elimination of errors represents the ceiling of what current technology can achieve. (NCBI PMC8678992, 2021)
41. 30–60% relative reduction (BCMA alone) — BCMA technology alone achieves 30–60% relative reductions in medication administration error rates across a variety of care settings. This wide range reflects implementation quality, scanning compliance, and workflow design. (NCBI PMC8678992)
42. $3,000–$7,000 per ADE avoided — Preventing a single adverse drug event saves between $3,000 and $7,000 in direct healthcare costs. With thousands of ADEs preventable per hospital per year, eMAR delivers compelling financial return on investment. (TechTarget/AHRQ)
43. 4.6%–89% scanning compliance — Patient BCMA scanning compliance rates in real-world hospital settings range from 4.6% to 89% across different wards. This variability reveals that technology adoption without workflow optimization fails to deliver full error-reduction benefits. (BMJ Health Informatics, 2025)
44. 96% accuracy post-eMAR — Medication accuracy improved to 96% following eMAR implementation in one controlled hospital study. This reflects eMAR’s ability to enforce standardized processes and eliminate the manual entry errors endemic to paper MAR. (ResearchGate, 2021)
45. 50% documentation time reduction — eMAR Plus achieved a 50% reduction in medication administration documentation time at Antrim Care Home. Time savings of this magnitude allow nursing staff to redirect effort toward direct resident care. (eMAR Plus, 2025)
46. 1,400 daily medications in 100-resident facility — A typical assisted living community of 100 residents administers approximately 1,400 medications every day. This volume makes manual paper-based MAR not just inefficient but genuinely dangerous without digital support. (August Health, 2025)
47. 60+ concurrent medications per resident — Some senior living residents have more than 60 simultaneous medications on their eMAR profile. Polypharmacy at this scale makes AI-assisted interaction checking and eMAR analytics essential for safe care delivery. (August Health, 2025)
48. 16.6 million medications tracked — August Health tracked over 16.6 million medication administrations using its eMAR platform in its first year of operation. This data volume enables pattern recognition and safety analytics impossible with paper systems. (August Health, 2025)
49. eMAR reduces paper burden by ~80% — Healthcare facilities report approximately 80% reduction in paper-based medication records after eMAR implementation. Reduced paperwork means less risk of lost records, illegible handwriting errors, and audit failures. (eMAR Plus, 2025)
50. Nurse medication errors 30–70% detected by peers — Nurses and pharmacists identify approximately 30–70% of medication-ordering errors before administration. eMAR’s automated alert layer catches errors that even well-trained clinical staff may miss. (DosePacker, 2026)
51. Outpatient home error rate 2–23% — Medication errors at home occur at rates of 2–23%, depending on patient literacy, care complexity, and support structure. Remote/mobile eMAR platforms are emerging to close this gap beyond institutional care settings. (DosePacker, 2026)
52. 1 in 131 outpatient deaths — The Institute of Medicine estimated that medication errors caused 1 in 131 outpatient deaths and 1 in 854 inpatient deaths. Modern eMAR systems with prescribing integration address the full care continuum, not just the bedside. (StatPearls via IOM)

---

🏆 Vendor Landscape & Market Share (Stats 53–66)

53. 43.7% Epic EHR market share (2025) — Epic Systems controls 43.7% of the U.S. acute care EHR and integrated eMAR hospital market in 2025, marking its fifth consecutive year of market share growth. Its dominance means the majority of U.S. hospital medication administrations rely on Epic’s eMAR module. (KLAS Research, 2026)
54. 54.9% of hospital beds (Epic) — Epic’s share of U.S. acute care hospital beds reached 54.9% in 2025 — meaning more than half of all inpatient medication passes occur within Epic’s eMAR ecosystem. (KLAS Research, 2026)
55. 21.9% Oracle Health share — Oracle Health (formerly Cerner) holds 21.9% of the acute care EHR/eMAR market, though it continues to lose ground with a net loss of 56 hospitals in 2025. (KLAS Research, 2026)
56. 14.7% MEDITECH share — MEDITECH is the third-largest acute care eMAR vendor at 14.7% market share, with strong customer retention among legacy community hospitals. (KLAS Research, 2026)
57. #1 PointClickCare in LTC — PointClickCare is ranked #1 in long-term care eMAR and EHR market share according to KLAS Research, receiving the highest overall satisfaction ratings among LTC-focused vendors. (KLAS Research, 2023)
58. #2 MatrixCare in LTC — MatrixCare holds the second-largest LTC eMAR market share and is recognized for robust clinical workflow support and strong interoperability partnerships, including real-time pharmacy integrations. (KLAS Research, 2023)
59. Epic won ~70% of new hospital contracts (2024) — In 2024, Epic won approximately 70% of all new hospital EHR purchase decisions — nearly all of which include integrated eMAR functionality. (KLAS Research, 2025)
60. +176 hospitals net for Epic (2024) — Epic added a net 176 acute care hospitals in 2024, its largest-ever annual gain, while Oracle lost 74 and MEDITECH lost 57. This consolidation accelerates the standardization of Epic-based eMAR workflows. (KLAS Research, 2025)
61. +77 hospitals net for Epic (2025) — Despite an overall market slowdown in 2025, Epic added 77 net hospitals — with all large-system decisions going to Epic, further cementing its eMAR dominance. (KLAS Research, 2026)
62. 84% MEDITECH customer retention — MEDITECH achieved 84% retention of legacy customers in 2025, demonstrating that established eMAR workflows create significant switching barriers even when competitors offer newer features. (KLAS Research, 2026)
63. Hospital EHR purchases down 40% (2025) — The number of hospitals impacted by EHR/eMAR purchase decisions dropped 40% in 2025 versus 2024, as policy uncertainty and investment shifts toward AI slowed procurement cycles. (KLAS Research, 2026)
64. Top 5 LTC vendors = ~35% revenue — The top five LTC software vendors controlled close to 35% of total LTC software revenue in 2024 — a moderately fragmented market where M&A activity is intensifying. (Mordor Intelligence, 2025)
65. 7,500+ facilities using ECP eMAR — ECP’s eMAR platform serves more than 7,500 senior living and long-term care communities as of 2024, making it one of the most widely deployed dedicated eMAR solutions in the U.S. (ECP, 2024)
66. $6.7B preventable rehospitalization cost — PointClickCare’s PAC Management solution targets the $6.7 billion annual cost of preventable rehospitalizations — a direct clinical and financial use case for integrated LTC eMAR platforms. (PointClickCare, 2024)

---

📈 Adoption, Demographics & Care Settings (Stats 67–82)

67. 1.6M+ U.S. certified nursing home beds — The U.S. operates over 1.6 million certified nursing home beds, all subject to CMS medication management requirements that effectively mandate eMAR adoption. (CMS via Precedence Research)
68. ~15,000 U.S. nursing homes — Approximately 15,000 Medicare- and Medicaid-certified nursing homes operate across the U.S., representing a vast deployment market for LTC-specialized eMAR systems. (The Senior List, 2026)
69. 1.2M+ nursing home residents — Over 1.2 million people reside in U.S. nursing homes — all receiving daily medications that must be tracked, documented, and reconciled through eMAR-compliant systems. (The Senior List, 2026)
70. 70% of adults will need LTC — Approximately 70% of U.S. adults will need some form of long-term care in their lifetime — creating an expanding demographic base requiring eMAR-supported medication management for decades to come. (SingleCare, 2026)
71. 220,000+ Australian aged care places — Australia reported over 220,000 residential aged care places in 2024–25, with mandatory digital medication management reforms actively expanding eMAR deployment requirements across the sector. (AIHW)
72. 31.1% home care segment share — Home care agencies accounted for the largest LTC software sub-segment at 31.1% of revenue in 2024, with mobile-delivered eMAR increasingly essential for managing complex medication regimens in home settings. (Market.us)
73. 40% of U.S. adults with multiple chronic conditions — 40% of American adults have two or more chronic conditions, compounding medication complexity and creating both the clinical need and commercial demand for advanced eMAR platforms. (HHS)
74. 96% U.S. hospital EHR adoption — Approximately 96% of U.S. hospitals have adopted certified EHR technology — making the infrastructure for eMAR near-universal, and shifting the growth vector toward quality improvement and AI features. (ONC Health IT)
75. $2.41B U.S. LTC software (2025) — The U.S. LTC software market, including eMAR, reached $2.41 billion in 2025 and is projected to grow to $4.11 billion by 2033. This domestic market alone is a major growth engine for global eMAR vendors. (Grand View Research)
76. $31.8B global EHR/EMR market (2026) — The global EHR/EMR market is estimated at $31.8 billion in 2026, with eMAR embedded across virtually all major platforms as a non-negotiable clinical module. (Straits Research)
77. 8% CAGR ambulatory eMAR — Ambulatory care centers are the fastest-growing EHR/eMAR end-user segment at 8% CAGR through 2034, expanding beyond hospitals into specialist clinics, outpatient surgery centers, and urgent care. (Straits Research)
78. 6.2% CAGR Asia-Pacific — Asia-Pacific is the fastest-growing EHR/eMAR regional market at 6.2% CAGR, as India, China, Japan, and Southeast Asian nations accelerate national digital health rollouts that mandate electronic medication records. (Straits Research)
79. 76.4% U.S. share of North American LTC market — The United States holds 76.4% of the North American LTC software market, reflecting the depth of regulatory mandates and commercial investment in eMAR across U.S. care facilities. (Market Data Forecast, 2025)
80. EHR hospital segment = 59% of market — Hospitals account for 59% of EHR/eMAR market revenue in 2025, confirming that acute care remains the dominant deployment environment even as LTC and ambulatory adoption rapidly close the gap. (Straits Research)
81. 45.1% cloud LTC revenue (2025) — Cloud-based LTC software platforms generated 45.1% of total LTC software revenue in 2025, with eMAR-as-a-service becoming the dominant deployment model for facilities of all sizes. (Mordor Intelligence)
82. $4.97B North American LTC by 2034 — The North American LTC software market is projected to reach $4.97 billion by 2034, growing at 11% CAGR — a sustained growth rate that will transform eMAR from early-majority to universal standard adoption. (Nova One Advisor)

---

🤖 Technology Trends & Innovation (Stats 83–100)

83. AI alert optimization active in 2024 — AI methods are now actively deployed within BCMA-eMAR systems to optimize medication alert thresholds, reducing alert fatigue — a previously major barrier to consistent clinical adoption of eMAR safety features. (JAMIA/NCBI, 2024)
84. PointClickCare AI Referral Advisor (Jan 2024) — PointClickCare launched an AI-powered Referral Advisor integrated with its eMAR for skilled nursing facilities in January 2024, automating clinical data extraction and accelerating admissions workflows. (Grand View Research / PointClickCare)
85. MatrixCare real-time pharmacy alerts (Mar 2024) — In March 2024, MatrixCare partnered with a national pharmacy to deliver real-time medication verification and automated dispensing alerts directly within its LTC eMAR platform. (Market Data Forecast, 2025)
86. August Health launches next-gen eMAR (Feb 2025) — August Health officially launched its next-generation eMAR for U.S. senior living operators in February 2025, featuring polypharmacy analytics, enterprise-level oversight, and real-time med-pass monitoring. (Grand View Research / August Health)
87. CharmHealth × PointClickCare bidirectional integration (Jan 2026) — In January 2026, CharmHealth and PointClickCare announced a bidirectional EHR-eMAR integration enabling seamless post-acute care data exchange — a key step toward interoperable medication records. (Grand View Research)
88. Microsoft Azure OpenAI integrated with Epic eMAR (2023) — Microsoft and Epic expanded their partnership in 2023 to integrate Azure OpenAI Service with Epic’s EHR and eMAR platform, accelerating generative AI use cases in clinical documentation and medication management. (Fortune Business Insights)
89. WellSky + Google Cloud AI (2024) — WellSky invested in generative AI documentation tools co-developed with Google Cloud in 2024, automating clinical charting within LTC eMAR and freeing nursing time previously consumed by manual documentation. (Mordor Intelligence)
90. 229,000 LTC caregivers lost since 2020 — The long-term care sector lost approximately 229,000 caregivers since February 2020, making the operational efficiency gains of eMAR — fewer manual steps, automated alerts — a staffing-crisis survival tool. (SingleCare, 2026)
91. 58% of nursing homes plan staff reductions — 58% of nursing homes anticipated staff reductions due to declining Medicaid reimbursement in 2025, making eMAR’s ability to sustain medication safety with fewer personnel financially critical to facility viability. (AHCA Survey, 2025)
92. SOC 2 Type II eMAR compliance (2024) — ECP achieved SOC 2 Type II compliance without qualification in August 2024, reflecting the growing importance of cybersecurity certification for eMAR vendors handling protected health information. (ECP, 2024)
93. Mobile-first eMAR is now baseline (2025+) — As of 2025, mobile-first eMAR platforms with voice input, AI clinical decision support, and real-time pharmacy integration are considered baseline expectations — not premium features — by LTC procurement teams. (ECP, 2024)
94. TEFCA interoperability driving eMAR data exchange — The Trusted Exchange Framework and Common Agreement (TEFCA) is driving nationwide health information exchange, with eMAR data increasingly required to flow seamlessly across care transitions. (KLAS Research, 2025)
95. Predictive analytics for medication adherence — Next-generation eMAR platforms are deploying predictive analytics to forecast medication adherence patterns, enabling care teams to intervene proactively before missed doses create clinical complications. (ECP, 2024)
96. $528B U.S. drug-related morbidity & mortality cost — The total annual U.S. cost of drug-related morbidity and mortality was estimated at $528 billion (2016 baseline), a figure that has grown significantly since — framing eMAR adoption as a trillion-dollar opportunity in harm prevention. (JMCP/SingleCare)
97. eMAR encryption & HIPAA compliance as standard — As data breach costs rise, eMAR platforms in 2025 feature advanced encryption, HIPAA audit-ready logging, and multi-factor authentication as non-negotiable baseline features rather than optional upgrades. (ECP, 2024)
98. Epic Community Connect expanding to small hospitals — Seven smaller standalone hospitals chose Epic’s Community Connect eMAR/EHR solution in 2025, extending enterprise-grade medication management to organizations with fewer than 200 beds. (KLAS Research, 2026)
99. Nordic Capital acquires Sensio for smart-sensor + eMAR — Nordic Capital’s acquisition of Sensio added smart-sensor resident monitoring capabilities to its LTC portfolio, reflecting private equity conviction that AI-sensor + eMAR integration is the next frontier of resident safety. (Mordor Intelligence, 2025)
100. PointClickCare Azure migration underway — PointClickCare’s migration to Microsoft Azure is enabling faster AI feature rollouts, multi-facility analytics consolidation, and enhanced eMAR uptime SLAs — setting a new benchmark for cloud-native LTC medication management platforms. (Mordor Intelligence, 2025)

Conclusion

The Top 100 eMAR System Statistics, Data & Trends in 2026 highlight the growing importance of Electronic Medication Administration Record (eMAR) systems in modern healthcare. As healthcare organizations face increasing pressure to improve patient safety, reduce medication errors, manage workforce shortages, and optimize operational efficiency, eMAR software is evolving from a digital documentation tool into an essential component of healthcare technology infrastructure.

The global eMAR software market reflects this transformation. With an estimated market value of $1.42 billion in 2024 and projected growth to $3.83 billion by 2033, the industry is positioned for sustained expansion. Increasing investment in electronic health records (EHR), barcode medication administration (BCMA), cloud-based healthcare software, and artificial intelligence is creating new opportunities for eMAR vendors and healthcare providers worldwide.

One of the most significant findings from the eMAR statistics is the technology’s potential to improve medication safety. Medication errors remain a major global healthcare challenge, with the World Health Organization estimating their annual economic burden at approximately $42 billion. Clinical research demonstrates that barcode-assisted electronic medication administration can reduce non-timing medication errors by 41.4% and potential adverse drug events by 51%. These findings reinforce the importance of integrating eMAR systems with barcode verification, clinical decision support, and standardized medication administration workflows.

Beyond reducing medication errors, eMAR systems are becoming increasingly valuable for improving nursing productivity and healthcare operational efficiency. Automated documentation, real-time medication tracking, pharmacy integration, and electronic audit trails can help healthcare professionals spend less time on administrative tasks and more time delivering direct patient care. These benefits are particularly relevant to nursing homes, assisted living communities, and long-term care facilities managing complex medication regimens with limited staffing resources.

The competitive landscape is also undergoing significant changes. Established healthcare technology providers such as Epic Systems, Oracle Health, MEDITECH, PointClickCare, and MatrixCare continue to influence the market through integrated EHR and medication management solutions. At the same time, specialized eMAR software providers are introducing cloud-native platforms, mobile medication administration applications, and advanced analytics capabilities to serve healthcare organizations of different sizes.

Looking ahead, several key eMAR system trends are expected to shape the industry beyond 2026, including:

• Artificial Intelligence and Predictive Analytics: AI-powered medication alerts, clinical decision support, and predictive adherence monitoring are expected to improve medication management and help healthcare professionals identify potential risks earlier.
• Cloud-Based eMAR Software Adoption: Healthcare providers are increasingly evaluating scalable cloud solutions that support remote access, centralized medication records, automatic updates, and reduced infrastructure requirements.
• EHR and Pharmacy System Integration: Greater interoperability between eMAR platforms, electronic health records, pharmacy management systems, and automated dispensing technologies will support more coordinated healthcare delivery.
• Mobile Medication Administration: Mobile-first eMAR applications will continue to support bedside documentation, barcode scanning, real-time medication verification, and more flexible nursing workflows.
• Patient Safety and Regulatory Compliance: Growing emphasis on medication safety, healthcare data protection, audit readiness, and clinical accountability will influence eMAR software procurement and implementation decisions.
• Long-Term Care Digital Transformation: Aging populations, increasing medication complexity, and persistent staffing challenges will accelerate demand for electronic medication administration solutions in nursing homes, assisted living facilities, and home healthcare settings.

However, successful eMAR implementation requires more than purchasing advanced software. Healthcare organizations must also prioritize staff training, workflow optimization, accurate medication data, cybersecurity, system interoperability, and consistent barcode scanning practices. The wide variation in reported scanning compliance rates demonstrates that technology alone cannot guarantee improved patient safety without effective implementation and ongoing monitoring.

For healthcare executives, nursing administrators, clinical informatics specialists, and technology decision-makers, the findings presented in these 100 eMAR system statistics for 2026 provide valuable insights into market opportunities, clinical outcomes, technology adoption, and future investment priorities.

Ultimately, the future of electronic medication administration record systems will be defined by their ability to combine medication safety, operational efficiency, intelligent automation, and seamless healthcare data integration. As healthcare organizations continue their digital transformation journeys, eMAR solutions are likely to play an increasingly important role in reducing preventable medication errors, supporting healthcare professionals, and improving the quality of patient care.

The central takeaway is clear: eMAR systems are no longer simply electronic replacements for paper medication records. They are becoming critical digital healthcare tools that support safer medication administration, more efficient clinical workflows, and data-driven healthcare management in 2026 and beyond.

If you find this article useful, why not share it with your hiring manager and C-level suite friends and also leave a nice comment below?

We, at the 9cv9 Research Team, strive to bring the latest and most meaningful data, guides, and statistics to your doorstep.

To get access to top-quality guides, click over to 9cv9 Blog.

To hire top talents using our modern AI-powered recruitment agency, find out more at 9cv9 Modern AI-Powered Recruitment Agency.

People Also Ask

What is an eMAR system in healthcare?

An Electronic Medication Administration Record (eMAR) system is digital software that tracks, documents, and manages medication administration. It helps healthcare providers improve patient safety, reduce documentation errors, and maintain accurate medication records.

How big is the global eMAR software market in 2026?

The global eMAR software market was valued at approximately $1.42 billion in 2024 and is projected to reach $3.83 billion by 2033. Increasing healthcare digitization, medication safety requirements, and cloud-based adoption are driving market expansion.

What is the projected growth rate of the eMAR market?

The global eMAR software market is projected to grow at a compound annual growth rate (CAGR) of approximately 11.8% from 2024 to 2033, supported by increasing demand for digital medication management and healthcare automation.

How do eMAR systems reduce medication errors?

eMAR systems reduce medication errors through electronic documentation, medication alerts, barcode verification, and real-time administration tracking. Research shows barcode-assisted eMAR can reduce non-timing medication errors by 41.4%.

What are the biggest eMAR system trends in 2026?

Major eMAR trends in 2026 include artificial intelligence, cloud-based medication management, mobile applications, barcode medication administration, predictive analytics, pharmacy integration, and improved interoperability with electronic health records.

What is the difference between eMAR and EHR systems?

An eMAR system specifically records and manages medication administration, while an Electronic Health Record (EHR) system manages broader patient information, including diagnoses, treatments, medical histories, and clinical documentation.

What is barcode medication administration (BCMA)?

Barcode Medication Administration (BCMA) uses barcode scanning to verify patients and medications before administration. When integrated with eMAR systems, it improves medication accuracy, reduces administration errors, and strengthens patient safety.

How effective are BCMA and eMAR systems at preventing adverse drug events?

Research indicates that barcode-assisted eMAR systems can reduce potential adverse drug events by approximately 51%. Effectiveness depends on scanning compliance, staff training, system integration, and consistent medication administration procedures.

How much do medication errors cost healthcare systems annually?

The World Health Organization estimates that medication errors cost approximately $42 billion globally each year. These costs include additional medical treatment, hospitalizations, complications, and preventable healthcare expenses.

Which companies lead the eMAR software market in 2026?

Major eMAR software providers include Epic Systems, Oracle Health, MEDITECH, PointClickCare, MatrixCare, ECP, and August Health. These companies serve hospitals, nursing homes, assisted living communities, and long-term care facilities.

What is Epic Systems’ market share in healthcare software?

According to the supplied 2026 market data, Epic Systems held approximately 43.7% of the U.S. acute care hospital EHR market in 2025 and served 54.9% of hospital beds. These figures represent EHR market share rather than standalone eMAR market share.

Why are nursing homes adopting eMAR software?

Nursing homes adopt eMAR software to improve medication accuracy, manage complex prescriptions, reduce paperwork, support regulatory compliance, and increase caregiver efficiency. Digital medication records are especially valuable in long-term care environments.

How does eMAR software improve nursing productivity?

eMAR software improves nursing productivity by automating medication documentation, reducing manual recordkeeping, providing medication reminders, and streamlining administration workflows. One care home case study reported a 50% reduction in documentation time.

What percentage of hospitals use electronic health records?

Approximately 96% of U.S. hospitals have adopted certified electronic health record technology, according to the supplied data. This widespread EHR adoption provides an established foundation for integrated eMAR systems.

What are the benefits of cloud-based eMAR systems?

Cloud-based eMAR systems offer centralized medication records, real-time updates, remote accessibility, easier software maintenance, and scalable deployment. They can help healthcare organizations reduce infrastructure requirements and improve medication management coordination.

How is artificial intelligence transforming eMAR systems?

Artificial intelligence is enhancing eMAR systems through medication risk alerts, predictive adherence analytics, clinical decision support, and automated documentation. These capabilities can help healthcare professionals identify potential medication problems earlier.

What is the role of eMAR software in long-term care facilities?

eMAR software supports medication scheduling, administration tracking, prescription verification, pharmacy coordination, and regulatory documentation in long-term care facilities. It helps caregivers manage complex medication regimens across multiple residents.

How large is the long-term care software market?

The global long-term care software market, which includes eMAR solutions, was valued at approximately $5.51 billion in 2024 and is projected to reach $12.52 billion by 2032, reflecting increasing investment in digital care management.

What is the difference between eMAR and traditional paper MAR?

Traditional Medication Administration Records rely on handwritten documentation, while eMAR systems digitally record medication administration. Electronic systems offer real-time updates, automated alerts, clearer audit trails, and reduced reliance on paperwork.

How do eMAR systems support medication safety compliance?

eMAR systems support medication safety compliance through electronic audit trails, medication verification, administration timestamps, access controls, and standardized documentation. These features help healthcare organizations monitor medication practices and prepare for audits.

Can eMAR systems prevent all medication administration errors?

No. eMAR systems can significantly reduce medication administration errors, but they cannot eliminate every risk. Human factors, incorrect data, barcode scanning failures, and workflow problems can still cause errors despite electronic safeguards.

What is the future of eMAR software beyond 2026?

The future of eMAR software includes greater AI integration, predictive medication monitoring, mobile-first applications, improved interoperability, cloud-based platforms, and automated pharmacy connections. These developments aim to improve medication safety and clinical efficiency.

How does eMAR software integrate with pharmacy systems?

eMAR software integrates with pharmacy systems to exchange medication orders, prescription updates, dispensing information, and administration records. This connectivity helps healthcare providers maintain accurate medication lists and coordinate medication management.

What are the main challenges of implementing eMAR systems?

Common eMAR implementation challenges include software costs, staff training, workflow disruption, system interoperability, cybersecurity, data migration, and barcode scanning compliance. Successful implementation requires planning, clinical engagement, and ongoing monitoring.

How much can eMAR systems reduce healthcare documentation time?

One eMAR Plus implementation at Antrim Care Home reported a 50% reduction in medication administration documentation time. Actual savings vary depending on facility size, existing workflows, software functionality, and staff training.

Why is mobile eMAR software becoming popular?

Mobile eMAR software allows healthcare professionals to access medication records, scan barcodes, document administration, and receive alerts at the point of care. It supports flexible workflows across hospitals, nursing homes, assisted living facilities, and home healthcare.

What percentage of medication errors can barcode scanning prevent?

Clinical research cited in the supplied data reports that barcode-assisted eMAR reduced non-timing medication administration errors by 41.4%. Other studies report different reductions depending on care settings, implementation quality, and scanning compliance.

How does eMAR software improve patient safety in hospitals?

eMAR software improves patient safety by supporting medication verification, electronic administration records, clinical alerts, and accurate documentation. Integration with barcode scanning can help prevent wrong-patient, wrong-medication, and wrong-dose errors.

What should healthcare organizations consider when choosing eMAR software?

Healthcare organizations should evaluate medication safety features, EHR integration, barcode scanning, pharmacy connectivity, usability, cybersecurity, regulatory compliance, implementation costs, vendor support, and scalability when selecting eMAR software.

Why are eMAR system statistics important for healthcare organizations in 2026?

eMAR system statistics help healthcare leaders understand market growth, medication safety outcomes, software adoption, and emerging technologies. These insights support informed purchasing decisions, digital transformation strategies, and improvements in medication management.

Sources

• Grand View Research
• Data Bridge Market Research
• World Health Organization (WHO)
• StatPearls
• KLAS Research
• Becker’s Hospital Review
• Fierce Healthcare
• CNBC
• Dark Daily
• HIT Consultant
• Mordor Intelligence
• Market Data Forecast
• Market.us
• Nova One Advisor
• Straits Research
• Spherical Insights
• Fortune Business Insights
• SingleCare
• DosePacker
• ECP
• August Health
• National Center for Biotechnology Information (NCBI)
• Oxford Academic
• Healthcare IT News